Relative performance of flomoxef compared to carbapenems from the treatment of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli or even Klebsiella pneumoniae using increased exposure of bare minimum inhibitory power of flomoxef: any retrospective research.